Aidapak Recalls CapsuleTOPRIL Tablets Due to Potential Labeling Error
Aidapak Services, LLC is recalling CapsuleTOPRIL tablets because they may have been mislabeled as Calcitriol capsules. The error could lead to patients receiving the wrong medication.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling CapsuleTOPRIL, Tablet, 12.5 mg (NDC 00143117101) due to a potential labeling error. The recalled product may have been mislabeled as CALCITRIOL, Capsule, 0.25 mcg (NDC 00054000725). The affected product has the pedigree AD52778_16 and an expiration date of 5/20/2014.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. This recall is classified as FDA Class II, indicating a situation that might temporarily cause or contribute to reversible adverse health consequences.
Healthcare providers and patients should check their inventory and prescriptions for CapsuleTOPRIL tablets with the specified pedigree and expiration date. If the product is found, it should be returned to the distributor or pharmacy for replacement or refund. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- CapsuleTOPRIL, Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00143117101.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- CapsuleTOPRIL
- Tablet
- 12.5 mg has the following codes: Pedigree: AD52778_16
- EXP: 5/20/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Calcitriol Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateFosinopril Sodium Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Allopurinol Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Mislabeled HydrALAZINE HCl Tablets
FDA (Drugs) · 2014-01-22
- ModerateRamipril Capsules Recalled for Potential Label Mixup with Other Medications
FDA (Drugs) · 2014-01-22
- SevereAspirin Tablets Recalled for Potential Mislabeling as Cholecalciferol
FDA (Drugs) · 2014-01-22